- Home
- CPS vs CRMD Comparison
CPS vs CRMD Comparison
Compare CPS & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CPS | CRMD |
|---|---|---|
| Founded | 1960 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 544.9M | 626.0M |
| IPO Year | 2005 | 2009 |
Fundamental Metrics
Financial Performance| Metric | CPS | CRMD |
|---|---|---|
| Price | $30.19 | $8.39 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $51.88 | $14.83 |
| AVG Volume (30 Days) | 143.9K | ★ 1.3M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 94.87 | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | $4.42 | $0.30 |
| Revenue Next Year | $6.36 | N/A |
| P/E Ratio | ★ N/A | $19.14 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $20.38 | $6.13 |
| 52 Week High | $47.98 | $17.43 |
Technical Indicators
Market Signals| Indicator | CPS | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 58.10 | 59.49 |
| Support Level | $30.64 | $6.14 |
| Resistance Level | $32.05 | $8.54 |
| Average True Range (ATR) | 1.39 | 0.30 |
| MACD | 0.35 | 0.00 |
| Stochastic Oscillator | 96.74 | 82.78 |
Price Performance
Historical ComparisonAbout CPS Cooper-Standard Holdings Inc.
Cooper-Standard Holdings Inc is engaged in the manufacture of sealing and fluid handling systems (consisting of fuel and brake delivery systems and fluid transfer systems). Its products are designed for passenger vehicles and light trucks that are manufactured by automotive original equipment manufacturers (OEMs) and replacement markets. It has two reportable segments: Sealing Systems and Fluid Handling Systems. The group's geographic regions are North America, Europe, Asia Pacific, and South America.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.